動画検索
関連広告
検索結果
speech & language developmental delays
Prof. Nahum Sonenberg Chair in Biochemistry
Prof. Randi Hagerman Professor, Pediatrics Medical Director of Mind Institute
Dr. Michael Tranfaglia MD & CSO. Fraxa Research Foundation
Alison Singer President, Autism Science Foundation
Prof. Mark Bear Neuroscientist Picower Institute
Prof. Peter Kind Professor of Developmental Neuroscience
Intro
Hui Cai (WuXi Apptec) – Welcome
Katie Clapp (FRAXA) – Welcome
Elizabeth Berry-Kravis (RUSH University Med Ctr), Peter Kind (University of Edinburgh), Michael Tranfaglia (FRAXA) – Opening Plenary
Kathryn Whitehead (Carnegie Mellon Univ.) – mRNA Replacement
David Hampson (Univ of Toronto) – Gene Therapy
Ralph Laufer (Lysogene) – Gene Therapy
Ernest Pedapati (Univ. of Cincinnati) – Protein Replacement
Stephen O’Quinn (Zynerba) – Targeted Therapy
Adrian Newman-Tencredi (Neurolixis) – Targeted Therapy
Lili Mao (GexVal) – Targeted Therapy
Daniel Alkon (Synaptogenix) – Targeted Therapy
Mara Dierssen (Centre for Genomic Regulation) – Targeted Therapy
Lynn Durham (Stalicla) – Targeted Therapy
Christopher Missling (Anavex) – Targeted Therapy
Robert Ring (Kaerus) – Targeted Therapy
David Walker (Sentinel Oncology) – Targeted Therapy
Bruce Bloom (Healx), Andres Centellas (FRAXA) – Drug Repurposing
Michael Hayden (Prilenia) – Drug Repurposing
Mahmoud Pouladi (Univ. of British Columbia) – Drug Repurposing
Isaac Bentwich (Quris-AI) – Drug Repurposing
George Drakakis (Purposeful) – Drug Repurposing
Nik Subramanian (Kantify) – Drug Repurposing
Gordon Wang (Stanford Univ) – Drug Repurposing
Richard Soll (WuXi Apptec) – Closing Remarks